Outcomes of patients with severe and critical COVID-19 treated with dexamethasone: a prospective cohort study

Dexamethasone implementation for COVID-19 management represented a milestone but data regarding its impact and safety have not been consistently reproduced. We aimed to evaluate in-hospital mortality before and after the implementation of corticosteroid treatment (CS-T) for severe and critical COVID...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez-Guerra, Bernardo A., Gonzalez-Lara, Maria F., Roman-Montes, Carla M., Tamez-Torres, Karla M., Dardón-Fierro, Francisco E., Rajme-Lopez, Sandra, Medrano-Borromeo, Carla, Martínez-Valenzuela, Alejandra, Ortiz-Brizuela, Edgar, Sifuentes-Osornio, Jose, Ponce-de-Leon, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Coronaviruses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725849/
https://www.ncbi.nlm.nih.gov/pubmed/34839785
http://dx.doi.org/10.1080/22221751.2021.2011619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725849/
https://www.ncbi.nlm.nih.gov/pubmed/34839785
http://dx.doi.org/10.1080/22221751.2021.2011619

Ejemplares similares